Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Genes & Development|June 17, 2010
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenanceJan van Riggelen, Judith Müller, Tobias Otto, et al.
BMJ Case Reports|September 11, 2012
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-CChristina A To, Robert W Hsieh, James Scott McClellan, et al.
Oncotarget|February 22, 2018
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)Renumathy Dhanasekaran, Meital Gabay-Ryan, Virginie Baylot, et al.
Cancer Research|December 16, 2022
MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory MacrophagesRenumathy Dhanasekaran, Aida S Hansen, Jangho Park, et al.
Blood|March 13, 2010
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemiaSylvie Giuriato, Marianne Foisseau, Emilie Dejean, et al.
Plos One|October 2, 2012
SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomasKyu Yun Jang, Sang Jae Noh, Nadja Lehwald, et al.
The American Journal of Pathology|January 24, 2009
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouseHyoung-gon Lee, Gemma Casadesus, Akihiko Nunomura, et al.
Oncogene|June 7, 2018
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinomaHeike Miess, Beatrice Dankworth, Arvin M Gouw, et al.
Science (New York, N.Y.)|March 12, 2016
MYC regulates the antitumor immune response through CD47 and PD-L1Stephanie C Casey, Ling Tong, Yulin Li, et al.
Cancer Cell|November 2, 2010
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationKavya Rakhra, Pavan Bachireddy, Tahera Zabuawala, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Genes & Development|June 17, 2010
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenanceJan van Riggelen, Judith Müller, Tobias Otto, et al.
BMJ Case Reports|September 11, 2012
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-CChristina A To, Robert W Hsieh, James Scott McClellan, et al.
Oncotarget|February 22, 2018
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)Renumathy Dhanasekaran, Meital Gabay-Ryan, Virginie Baylot, et al.
Cancer Research|December 16, 2022
MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory MacrophagesRenumathy Dhanasekaran, Aida S Hansen, Jangho Park, et al.
Blood|March 13, 2010
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemiaSylvie Giuriato, Marianne Foisseau, Emilie Dejean, et al.
Plos One|October 2, 2012
SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomasKyu Yun Jang, Sang Jae Noh, Nadja Lehwald, et al.
The American Journal of Pathology|January 24, 2009
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouseHyoung-gon Lee, Gemma Casadesus, Akihiko Nunomura, et al.
Oncogene|June 7, 2018
The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinomaHeike Miess, Beatrice Dankworth, Arvin M Gouw, et al.
Science (New York, N.Y.)|March 12, 2016
MYC regulates the antitumor immune response through CD47 and PD-L1Stephanie C Casey, Ling Tong, Yulin Li, et al.
Cancer Cell|November 2, 2010
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivationKavya Rakhra, Pavan Bachireddy, Tahera Zabuawala, et al.
Pageof 15